(Q27008502)

2

0 references

Louis Griffel

3

0 references

Neil Kaplowitz

4

0 references

Paul B Watkins

Creative Commons Attribution-NonCommercial 4.0 International

5

0 references

language of work or name

English

0 references

publication date

November 2014

0 references

1 November 2014

2 references

19 September 2019

22 August 2022

3 references

19 September 2019

22 August 2022

37 Suppl 1

0 references

page(s)

S57-62

0 references

issue

S1

0 references

copyright license

1 reference

Europe PubMed Central

https://scigraph.springernature.com/pub.10.1007/s40264-014-0186-3

22 August 2022

exact match

0 references

cites work

Methodology to assess clinical liver safety data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4212149

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4212149

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4212149

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4212149

Diagnosis, management, and treatment of hepatitis C: an update

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4212149

Effect of tyrosine kinase inhibitors on wound healing and tissue repair: implications for surgery in cancer patients

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4212149

A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical data

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4212149

Validation of multivariate outlier detection analyses used to identify potential drug-induced liver injury in clinical trial populations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4212149

Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4212149

Hepatic profile analyses of tipranavir in Phase II and III clinical trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4212149

Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4212149

Predictors of antiretroviral-related hepatotoxicity in the adult AIDS Clinical Trial Group (1989-1999).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4212149

Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4212149

AGA technical review on the evaluation of liver chemistry tests

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4212149

The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4212149

Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

28 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0186-3

Background incidence of liver chemistry abnormalities in a clinical trial population without underlying liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0186-3

Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0186-3

Reexamining transaminase elevation in Phase I clinical trials: the importance of baseline and change from baseline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0186-3

Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0186-3

HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0186-3

Why the threshold criteria should not be modified for detection of possibly serious drug-induced hepatotoxicity in special groups of trial subjects

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25352328

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hepatotoxicity of antiretrovirals: incidence, mechanisms and management

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25352328

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25352328